Medtronic plc has announced the launch of InPen™ integrated with real-time Guardian Connect™ CGM data. InPen...
QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by labora...
PerkinElmer, Inc. has launched its newest ChemDraw® application, ChemOffice®+ Cloud, to simplify, faci...
PerkinElmer, Inc., announced on 9 Oct 2020 that EUROIMMUN, a PerkinElmer company, has launched the Anti-S...
Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...
Thermo Fisher Scientific and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University i...
PerkinElmer, Inc. and Horizon Discovery Group plc have announced that they have reached an agreement on t...
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international p...
Merck has recently announced a collaboration with Mammoth Biosciences Inc. of South San Francisco, California, USA, for ...
PerkinElmer, Inc. announced on 29 Oct 2020 that the U.S. Food and Drug Administration (FDA) has...
The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to...
PerkinElmer, Inc. has announced that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received cl...
Avidity Science, a leader in water purification and delivery, control and monitoring and service solutions for the ...
PerkinElmer, Inc. has announced that a research team at the National Center for Advancing Translational Sciences&nb...
Stryker, one of the world's leading medical technology companies based in the US, has announced the global launch of the...
In line with its commitment to delivering the promise of proteomics to improve human health, Thermo Fisher Scientific ha...
Rapid expansion of digital healthcare for the provision of delivery, medical support, and intervention through mobile te...
Nine-month results: Order intake1 up 37.8 percent; sales revenue up 25.2 percent; underlying EBITDA1 margi...